INSULIN ISOPHANE HUMAN BIOSYNTHETIC — all Canadian products
5 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is INSULIN ISOPHANE HUMAN BIOSYNTHETIC, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 01959239 | HUMULIN N (CARTRIDGE) | ELI LILLY CANADA INC | Suspension | Subcutaneous | INSULIN ISOPHANE HUMAN BIOSYNTHETIC 100 UNIT | Marketed | |
| 02403447 | HUMULIN N (KWIKPEN) | ELI LILLY CANADA INC | Suspension | Subcutaneous | INSULIN ISOPHANE HUMAN BIOSYNTHETIC 100 UNIT | Marketed | |
| 02024225 | NOVOLIN GE NPH | NOVO NORDISK CANADA INC | Suspension | Subcutaneous | INSULIN ISOPHANE HUMAN BIOSYNTHETIC 100 UNIT | Marketed | |
| 02024268 | NOVOLIN GE NPH PENFILL | NOVO NORDISK CANADA INC | Suspension | Subcutaneous | INSULIN ISOPHANE HUMAN BIOSYNTHETIC 100 UNIT | Cancelled Post Market | |
| 02024403 | NOVOLINSET GE NPH INJ SUS 100U/ML | NOVO NORDISK A/S | Suspension | Subcutaneous | INSULIN ISOPHANE HUMAN BIOSYNTHETIC 100 UNIT | Cancelled Post Market |
Browse other molecules: